A. Kriplani

发表

Trends in chronic opioid therapy among survivors of head and neck cancer

D. Boudreau, N. Moryl, D. Korenstein, 2020, Head & neck.

Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer

N. Lee, I. Ganly, Bhuvanesh Singh, 2022, CA: a cancer journal for clinicians.

Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease

R. Holcombe, N. Harpaz, S. Itzkowitz, 2017, Clinical colorectal cancer.

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

N. Lee, I. Ganly, Bhuvanesh Singh, 2022, JAMA network open.

Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy.

A. Drilon, M. Voss, G. Iyer, 2021, JAMA ophthalmology.

The Head and Neck Survivorship Tool (HN-STAR) Trial (WF-1805CD): A protocol for a cluster-randomized, hybrid effectiveness-implementation, pragmatic trial to improve the follow-up care of head and neck cancer survivors.

J. Ostroff, A. Salner, T. Atkinson, 2021, Contemporary clinical trials.

Neutrophil-Lymphocyte Ratio (NLR), Platelet-Lymphocyte Ratio (PLR) and Lymphocyte-Monocyte Ratio (LMR) in predicting Systemic Inflammatory Response Syndrome (SIRS) and sepsis after Percutaneous Nephrolithotomy (PNL)

Alok Ratan Choudhary, A. Kriplani, A. Chawla, 2022, European Urology.

Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma

V. Rusch, M. Bains, K. Goodman, 2016, Cancer.

Safety of opioid prescribing among older cancer survivors

N. Moryl, D. Korenstein, A. Lipitz-Snyderman, 2021, Cancer.